Case number 2023-2317
In re: Entresto (Sacubitril/Valsartan) > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 23, 2023 | 1 | Appeal docketed. Received: 08/17/2023. [945341]Entry of Appearance due 09/06/2023. Certificate of Interest is due on 09/06/2023. Docketing Statement due 09/06/2023. Appellant's brief is due 10/23/2023. [MMA] [Entered: 08/23/2023 02:58 PM] (156) |
| Aug 23, 2023 | 2 | Entry of Appearance for Deanne E. Maynard; Seth W. Lloyd; Nicholas N. Kallas; Christina Schwarz as counsel for Appellant Novartis Pharmaceuticals Corporation. Service: 08/23/2023 by email. [945434] [23-2317] [Deanne Maynard] [Entered: 08/23/2023 05:44 PM] (2) |
| Aug 23, 2023 | 3 | Certificate of Interest for Appellant Novartis Pharmaceuticals Corporation. Service: 08/23/2023 by email. [945436] [23-2317] [Deanne Maynard] [Entered: 08/23/2023 05:48 PM] (2) |
| Aug 23, 2023 | 4 | Docketing Statement for the Appellant Novartis Pharmaceuticals Corporation. Service: 08/23/2023 by email. [945439] [23-2317] [Deanne Maynard] [Entered: 08/23/2023 05:52 PM] (3) |
| Aug 23, 2023 | 5 | Notice of Related Case Information for Appellant Novartis Pharmaceuticals Corporation. Service: 08/23/2023 by email. [945442] [23-2317] [Deanne Maynard] [Entered: 08/23/2023 05:54 PM] (4) |
